Literature DB >> 316807

Clonal analysis of the action of GM-CSF on the proliferation and differentiation of myelomonocytic leukemic cells.

D Metcalf.   

Abstract

With 214 subclones of the BALB/c myelomonocytic leukemia WEHI-3B, the granulocyte-macrophage colony-stimulating factor (GM-CSF) in impure or purified form, consistently increased the proportion of colonies exhibiting partial or complete differentiation in agar cultures. GM-CSF also increased colony size and content of daughter colony-forming cells. Serial recloning of WEHI-3B colonies in the presence of GM-CSF showed that when colonies differentiated completely, self-replication of the colony-forming cell was suppressed (clonal extinction). However, WEHI-3B cells exhibited clonal instability and even in the continuous presence of GM-CSF many colony-forming cells still generated cells able to form undifferentiated colonies. It appears unlikely that GM-CSF can completely suppress the progressive proliferation of a myeloid leukemic population of the WEHI-3B type.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 316807     DOI: 10.1002/ijc.2910240515

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

Review 1.  Preclinical and clinical studies with the hematopoietic colony-stimulating factors and related interleukins.

Authors:  H E Broxmeyer; S Vadhan-Raj
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

Review 2.  Is there a role for differentiating therapy in non-APL AML?

Authors:  H Phillip Koeffler
Journal:  Best Pract Res Clin Haematol       Date:  2010-11-23       Impact factor: 3.020

3.  Expression of leukemia inhibitory factor in human pituitary adenomas: a morphologic and immunocytochemical study.

Authors:  G Kontogeorgos; H Patralexis; A Tran; K Kovacs; S Melmed
Journal:  Pituitary       Date:  2000-05       Impact factor: 4.107

4.  Karyotype and in vitro-response to GM-CSF. Analysis of bone marrow cultures in leukemia, myelodysplasia and aplastic anemia.

Authors:  D Haase; C Fonatsch
Journal:  Blut       Date:  1990-03

5.  Molecular cloning and chromosomal localization of the murine homolog of the human helix-loop-helix gene SCL.

Authors:  C G Begley; J Visvader; A R Green; P D Aplan; D Metcalf; I R Kirsch; N M Gough
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

6.  Specific binding of murine leukemia inhibitory factor to normal and leukemic monocytic cells.

Authors:  D J Hilton; N A Nicola; D Metcalf
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

7.  Translation of lymphocyte mRNA for mouse colony stimulating factor.

Authors:  R C Bleackley; H Horak; J McElhaney; C Havele; A R Shaw; A R Turner; V H Paetkau
Journal:  Nucleic Acids Res       Date:  1983-05-25       Impact factor: 16.971

8.  Differentiation induction in myeloid leukemic cells.

Authors:  U Gullberg; K Peetre; I Olsson
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

9.  Expression of leukemia inhibitory factor in craniopharyngioma.

Authors:  A Tran; K Kovacs; L Stefaneanu; G Kontogeorgos; B W Scheithauer; S Melmed
Journal:  Endocr Pathol       Date:  1999-06       Impact factor: 3.943

10.  Molecular cloning and expression of the human homologue of the murine gene encoding myeloid leukemia-inhibitory factor.

Authors:  N M Gough; D P Gearing; J A King; T A Willson; D J Hilton; N A Nicola; D Metcalf
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.